Bank of New York Mellon »

Rigel Pharmaceuticals shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-06-30 $489k 60k 8.22

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Meta Platforms Inc-class A Cl A (META)
Ishares Core S&p 500 Etf Core (IVV)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Mastercard Inc - A Cl A (MA)
Taiwan Semiconductor-sp Spon (TSM)

View all positions for Bank of New York Mellon

Top funds holding Rigel Pharmaceuticals

Armistice Capital
BlackRock
Morgan Stanley
Soleus Capital Management
Vanguard Group
Susquehanna International
Acadian Asset Management
Assenagon Asset Management
Geode Capital Management
State Street Corporation
Stonepine Capital Management
Jacobs Levy Equity Management
Renaissance Technologies
Healthcare Of Ontario Pension Plan Trust Fund
Ing Investment Management

View all funds holding Rigel Pharmaceuticals